Navigation Links
Knockout Mouse Project

Children's Hospital & Research Center Oakland is leading one of two teams in an international effort to produce thousands of genetically altered mice for a study to understand the role of individual genes in human health. Other members of the team represent the School of Veterinary Science at the University of California, Davis and the Wellcome Trust Sanger Institute in Hinxton, England. The National Institutes of Health (NIH), announced the selection of the hospital's research institute for the Knockout Mouse Project (KOMP) on September 7, 2006.

The $50 million initiative funded by the NIH is intended to help researchers explore the functions of 10,000 mouse genes. Humans and mice share the same characteristics for most of the 10,000 mouse genes identified for this study. Researchers hope to catalogue and confirm the functions of these genes and identify the disease consequences if these genes are defective. Since human and mice genes are similar, it is hoped that by inactivating mouse genes, one-by-one, the altered mice will yield clues about the function of human genes and their similar roles in human diseases.

"The process is a long one, but the rewards are immeasurable," said Pieter de Jong, Ph.D., Children's Hospital Oakland Research Institute scientist and principle investigator for KOMP. "We're at the forefront of understanding the pathology of human genes. By knocking out each gene one-by-one, we will be able to create a central resource for researchers and scientists to use and study," said Dr. de Jong.

Children's Hospital Oakland Research Institute has a recombinant DNA library with more than 30 million DNA samples that are used in research programs around the world. The research institute's DNA library has become a major resource for ongoing global research in the genetics of human diseases. The recombinant DNA library is, for example, being used in Oakland to investigate the genetic differences that make certain peopl e susceptible to inherited forms of Lou Gehrig's Disease.

For the new "KOMP" project, Children's Hospital Oakland will create the genetic material that will be used to knockout or "inactivate" mouse genes. Scientists at the Wellcome Trust Sanger Institute in Hinxton, England will insert the altered genes into the embryonic stem cells derived from the mice. UC Davis will use the altered embryonic stem cells to create adult mice with one missing gene, which are referred to as "knockout mice."

This NIH-funded project will work closely with similar efforts in Canada and Europe to inactivate and study additional mouse genes. The projects provide new standards to ensure that scientists will be working from the same tested and proven methodology. Eventually, the project may expand to include large scale studies related to the pathology of the 10,000 knock-out mouse strains. For now, scientists say there is much to be learned from the current study.


'"/>

Source:Children's Hospital & Research Center at Oakland


Related biology news :

1. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
2. Mouse brain tumors mimic those in human genetic disorder
3. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
4. Mouse gene shows new mechanism behind cardiac infarction in man
5. Mouse with designer liver has enhanced glucose tolerance, insulin response
6. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
7. Mouse genome much more complex than expected
8. Mouse study: New muscle-building agent beats all previous ones
9. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
10. Mouse to man: The story of chromosomes
11. Mouse mimics chronic leukemia, will aid drug development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2019)... ... September 24, 2019 , ... A-Alpha Bio ... drug development, announced today that it has raised $2.8M from leading science-focused venture ... also includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, Sahsen Ventures, Washington ...
(Date:9/17/2019)... ... ... VISTAAR released ADVISORY Playbooks to help small and mid-level companies who ... their internal strategies they formed for developing or launching new products or expanding to ... to change their product elements and want to know the impact, introducing new product ...
(Date:9/14/2019)... , ... September 12, 2019 , ... ... manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced ... company’s biologics business. Dr. Schaffer has played an integral advisory role on the ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... of Hannah Holscher, PhD, RD, to its Scientific Advisory Board. Dr. Holscher is ... Nutrition and the Division of Nutritional Sciences at the University of Illinois Urbana-Champaign, ...
(Date:9/17/2019)... POWAY, Calif. (PRWEB) , ... September 17, 2019 , ... ... of osteoarthritis. At only four months old, Tucker was limping and lame on his ... hip and elbow dysplasia and it was called “the worst case the vet had ...
(Date:9/17/2019)... (PRWEB) , ... September 16, 2019 , ... ... Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings for ... Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... educate about the latest developments in genome sequencing analysis. Check your local listings ... taking place at Rivermap Research & Consulting and will explore its revolutionary pathogenic ...
Breaking Biology Technology: